Background/Aim.
Introduction
Acetylcholinesterase (E.C. 3.1.1.7) (AChE) and butyrylcholinesterase (E.C. 3.1.1.8) (BChE or BuChE) are enzymes from the group of hydrolases, which catalyze the hydrolytic reaction of choline esters in the presence of water molecules [1] [2] [3] . The difference between the two enzymes is based on their different affinity for certain choline esters. AChE hydrolyzes acetylcholine (ACh) and acetyl-β-methyl choline, but unlike BuChE it does not hydrolyze benzoylcholine. Also AChE rate of hydrolysis decreases with the longer length of carbohydrate chain from ACh, than propionyl chloride to butyrylcholine. One molecule of AChE can hydrolyse 25,000 molecules of ACh per second, terminating its effect on muscarinic and nicotinic receptors and impulse transmission. This enzyme is found in erythrocytes, neuromuscular junctions, lungs, spleen and in all compartments of the brain. Inhibition of enzyme leads to accumulation of ACh in central and peripheral nervous system and cholinergic hyperstimulation, manifested as cholinergic crisis. Determination of the activity of AChE (true cholinesterase), along with the clinical picture, is therefore used to confirm cholinesterase inhibitors [(organophosphates (OP) and carbamates, nerve agents)] poisoning [3] [4] [5] [6] . BuChE was known as plasmatic cholinesterase or pseudocholinesterase, and it is named according to its preference for the artificial substrate butyrylcholine. BuChE is also able to hydrolyze succinylcholine, adipoylcholine, benzoylcholine and propionylcholine 5 . The physiological role of this enzyme is still not known, but the clinical practice has shown that the use of suxamethonium in cases of genetic or acquired BuChE deficit may lead to neuromuscular block 7 . Although still under research, BuChE becomes increasingly promising therapeutic agent for detoxification of organophosphorus nerve agents and in cocaine abuse 6, 7 . BuChE is produced by the liver and is secreted into the circulation. BuChE is present in almost all tissues and in blood [6] [7] [8] [9] [10] [11] [12] . Reduced activity of this enzyme follows certain pathological conditions of the body (liver disease, malnutrition, acute infection, cancer, chronic anemia) 8 . Poisoning by OP pesticides can also cause a reduction of enzyme activity, as well as certain drugs (cimetidine, procainamide, androgens, estrogens, oral contraceptives, contrast agents, etc.) 9 . There are 2 types of pseudocholinesterases, normal (typical) and atypical. BuChE activity changes with age, with the lowest levels found in the newborn (about 60% of levels in healthy adults). According to some authors, a significant reduction of up to 30% BuChE activity occurs during pregnancy 11 . However, other authors have found that besides the genetic polymorphism, the difference in BuChE levels was not influenced by age, but only by body weight and height 12 . According to the World Health Organization, more than 3 million OPs poisonings, of which over 300,000 ends fatally, are registered annually. OPs irreversibly inhibit the enzyme AChE. The accumulation of the neurotransmitter ACh in the cholinergic synapses leads to the onset of symptoms and signs of acute poisoning. Besides reaction with AChE, OPs inhibit BuChE and other esterases 11 .
Determination of cholinesterase activity is of great importance to confirm or rule out poisoning by OPs and as an indicator of the condition of patients and the success of the applied therapy. The degree of the enzyme inhibition, among other criteria (clinical picture, the level of OPs in blood, dose of atropine applied), determines the severity of poisoning 8, 11 . Methods for determination of cholinesterases activity in preventive and clinical diagnostics should be simple, rapid, reliable, sensitive and specific. There are different methods for their determination but most often spectrometric method and enzyme immunoassay tests are used [13] [14] [15] [16] [17] [18] [19] . The estimation of the level of cholinesterase inhibition, corresponding to the severity of OP poisoning, depends on the normal values which show biological variations among different populations, mainly due to genetic polymorphism [20] [21] [22] [23] . Thus, it is important to determine their values in Serbian population, which has not been done so far. Therefore, the aim of this study was to determine the reference values for AChE and BuChE activities in a healthy population of adults in the Republic of Serbia.
Additionally, it was also intriguing to compare our results with the findings of the authors from other countries, and also to check the reliability of the previous estimation of ChE activity in our patients poisoned by OPs performed according to their findings.
Methods
The study was conducted on 851 volunteers, in order to determine the reference values of cholinesterases (AChE and BuChE) activity in the Republic of Serbia. The study was 
Determination of AChE
As Reagents we used: Indicator erythrocyte cholinesterase (DTNB, 5 mM); the substrate for erythrocyte cholinesterase (Acetylthiocholine iodide, 0.34 M) Phosphate buffer (Na 2 HPO 4 /KH 2 PO 4, 0.1 M -pH 7.4); Ethopropazine (6 mM).
Working conditions in the spectrophotometer GBC Cintra 10e: λ= 412 nm; recording speed range: 60 nm/min; slot width: 1.5 nm; total recording time: 180 s; the sample is taken via flow cuvette (cuvette length 10 mm). The method of sample preparation Not coagulated blood sample (anticoagulant K 2 EDTA) was centrifuged for 10 min at 3,000 rev/min. After centrifugation, the upper layer was rejected (plasma). The test tube was charged with 1 mL of hemolysate (6 mL distilled water and 10 ml of washed erythrocytes in phosphate buffer), 0.8 mL of phosphate buffer, 0.1 mL of indicators, 10 uL ethopropazine and finally 0.1 mL of substrate. Measurement of erythrocyte cholinesterase activity was carried out at 412 nm.
Analytical measurement range of this method was 700-12000 IU/L, and reference values were 4 000-8 000 IU/L.
The method for determining the activity of AChE 18 was validated in the Department for Toxicological Chemistry, Military Medical Academy. The method was accredited (validated documented method number 43).
Determination of BuChE
BChE activity in plasma was determined by the integrated chemical system (Dimension RxLMax) with ready-made reagent cartridge for analysis 19 . Range of measurement was from 0 to 14 U/mL (0-14000 U/L); reference values: 7,000 to 19,000 U/ L 24 . SPSS, U.18 (USA), software programme was used for statistical analysis. Normality of data distribution was evaluated by using Kolmogorov-Smirnov test. Mann-Whitney test and Kruskal-Wallis test were used for comparison between groups.
Results
In the group of 851 examinees, there were 728 males and 123 females of different ages. For all of them, the erythrocyte cholinesterase activity was determined. Due to technical reasons, BuChE activity was determined in 205 subjects (169 males and 36 females). Table 1 shows basic demographic characteristics of the examinees (gender, age) regarding AChE and BuChE determination. Although the examinees were predominantly males, there were no differences in relation to age structure and mean age for both sexes.
The basic parameters of descriptive statistics (mean, median, standard deviation, the minimum and maximum value of the selected variables with their difference -the scope of distribution) for AChE in both sexes are presented in Table 2. Kolmogorov-Smirnov test revealed that there was no normal distribution for data in the group of male examinees. Therefore, application of nonparametric statistics was necessary in further statistical analysis. Mann-Whitney test showed that there was no significant difference in average values of AChE activity between sexes, thus both gender groups were conjoined for further evaluation.
In accordance with the found data for AChE activity levels, the percentile distribution of AChE activity was calculated, and activity levels of 4,037.7 and 11,733.8 IU/L, corresponding to the position of 2.5 and 97.5 percentiles, respectively may be used for determination of lower and upper reference limits in a healthy population (Table 3) .
Descriptive statistics for BuChE in both sexes was similar as the one for AChE, as Kolmogorov-Smirnov test revealed that there was no normal distribution for data in males, and nonparametric statistics showed that there was no significant difference in average activity levels of BuChE between genders, so the groups were further evaluated as one ( Table 4) .
The percentile distribution of BuChE activity levels of examinees was calculated. The activity of 9,053.7 U/L corresponding to the position of 2.5 percentiles, and 23,671.8 U/L corresponding to the position of 97.5 percentiles may be used for determination of lower and upper reference limits of plasma BuChE activity in a healthy population (Table 5).
The activity levels of AChE and BuChE of examinees of different age categories were also analyzed.
Kruskal-Wallis test did not reveal significant changes among age category regarding AChE (χ 2 = 1.13; p = 0.76) as well as BuChE activity (χ 2 = 3.62; p = 0.30) (Figure 1 ). 
Disscusion
Inhibition of AChE and BuChE is one of the pertinent diagnostic criteria in acute anticholinesterases poisoning. Whilst the role of AChE is thoroughly investigated, the precise role of BuChE still remains unknown despite extensive scientific research. Besides being a sensitive indicator for confirmation of exposure to anticholinesterases and hepatic biosynthetic capacity, there are new trends of BuChE use as a biomarker and detoxifying agent in OP nerve agents poisoning. Except in occupationally exposed workers who should have predetermined baseline activity levels of cholinesterases, in acute poisonings whether accidental or suicidal, they are not readily available. Thus, the degree of poisoning has to be estimated according to the reference values, that may differ among laboratories due to different methods and techniques, and different populations. There are also inter-individual and intra-individual variations caused by genetic polymorphism, age, body weight, sex, height 12 . Considering the reported biological varitions of cholinesterase activity levels in different populations, it was important to determine their values in our population, which so far have not been done.
Determining the reference values is extensive work that involves selection of suitable reference persons, preparing them for standardized sampling, analyzing of samples, statistical data analysis and presentation of the results [25] [26] [27] . The Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommends that the establishment of reference intervals requires a minimum of 120 individuals in each subgroup 28 . The IFCC recommends estimating a confidence range of 95% for each limit of the reference interval in both Gaussian and non-Gaussian distribution 26, 29 . Manufacturers of biochemical reagents recommend that each laboratory determines its own reference ranges, because of characteristics of the population covered by certain laboratories 24 . According to the number of subjects (851 and 205) our study meets the criteria with relevant standards, as compared to other studies 20, 24, 28 . Examinees were voluntary blood donors who have denied that they have any disease, and who had not taken any medicine that affects cholinesterase activity. The mean value of acetylcholinesterase activity was 8,090.6 ± 1,976.7 IU/L, and of butyrylcholinesterase activity was 14,556.6 ± 4,078.1 U/L. In this presented small pilot study of examinees in whom AChE and BuChE activity levels were determined, there were no differences according to age structure and ranges for both sexes. This is similar to results of other studies which failed to identify age as a significant factor for biological variations of cholinesterases 20, 30 . Although most of our examinees were males, nonparametric statistics showed no significant difference of average AChE and BuChE activity levels between sexes, so both gender groups were analyzed as one group. By using KolmogorovSmirnov test, the lack of normal data distribution was revealed in male (AChE as well as BuChE subgroups). After the percentile distribution of cholinesterases activity levels of our examinees was calculated, activity levels of 4,037.7 and 11,733.8 IU/L for AChE, and 9,053.7 and 23,671.8 U/L for BuChE, corresponding to the positions of 2.5 and 97.5 percentiles, respectively, were proposed to be used for determination of lower and upper reference limits in a healthy population.
Various laboratories in U.S. have different reference ranges for the values of AChE and BuChE activity in a healthy population. Mayo Medical Laboratory has reference range for BuChE activity for males > 18 years from 3,100 to 6,500 U/L and females at the age 18-49 years from 1,800 to 6,600 U/L and for those over 50 years from 2,550 to 6,800 U/L 31 . In Quest Diagnostics Laboratory this range for BuChE for males is 3,342-7,586 U/L, and for females 2,637-6,592 U/L. AChE activity levels for both sexes are in the range of 9,572-15,031 IU/L The recommended normal values for cholinesterase activity vary according to values reported by other researchers, because tests were carried out on different populations (from various geographical areas, with racial, ethnic, nutritional status differences) 7, 10, 26, 29 . According to literature data, the reference values for AchE activity are in the range of 6,000 to 13,000 IU/L, and for BuChE for males 5,400-13,200 U/L and for female 3,700-9,300 U/L 33 . In our study, the activities of AChE and BuChE of examinees of different age categories were also analyzed. Kruskal-Wallis test did not reveal significant changes among age category regarding AChE as well as BuChE activity.
Based on this results, it seems reasonable to assume that unique reference intervals of AChE and BuChE are applicable for healthy subjects, regardless of their age.
With regard to the reference values for both cholinesterases, results of this pilot study are highly suggestive for the need to further evaluate the reference values for AChE and BuChE activity, expanding the study with other relevant parameters (including body weight) and a larger number of female patients for BuChE.
Conclusion
AChE and BuChE are important biomarkers of exposure to organophosphorus and carbamate insecticides. Inhibition of cholinesterase activity can also indicate the severity or course of poisoning and represents the useful gui- de for the therapy. Due to this, it is very important to provide the correct reference values. The results of this small pilot study of these enzymes activities in healthy population in the Republic of Serbia which has now been done for the first time indicate the need for considering their higher ranges when estimating the severity of poisoning. However, further studies for BuChE with the inclusion of a larger number of females and data for the weight of the examinees, in order to get more precise reference limits, are necessary.
The limitation of this pilot study is a small number of female examinees and the fact that other parameters, such as body weight, have not been taken into account, so further study with larger number of female examinees and body weight, is recommended.
